A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
Amgen has created a number of websites to better serve you with specific questions.
Despite progress in scientific research and available treatments and diagnostic tools, osteoporosis remains a global health problem with potentially devastating consequences for patients and significant costs for health care systems. This report, prepared by Ghent University, presents for the first time the strongest voice in the mission to increase awareness of osteoporosis and to advocate for proper diagnosis and treatment to prevent future fractures – the patients’ voice. Patients of both sexes and all ages, representing 14 countries worldwide, have shared their powerful experiences and perspectives reinforcing the need for early screening, intervention and appropriate post-fracture care. Joining the patients’ voice, Amgen calls on policymakers and health systems to prioritize integrated
people-centered osteoporosis care and elevate bone health to a national health priority to minimize the consequences of the disease.
